Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-31 @ 11:22 AM
Study NCT ID:
NCT03852433
Status:
COMPLETED
Last Update Posted:
2024-10-08
First Post:
2019-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)
Sponsor:
Gilead Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-02-21
First Submit QC Date:
None
Study First Post Date:
2019-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-24
Results First Submit QC Date:
None
Results First Post Date:
2024-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-07-29
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-10-08
Last Update Post Date Type:
ACTUAL